Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLC599 in Osteoarthritis of the Knee
NCT03005873Phase 2Completed
- Sponsor
- Taiwan Liposome Company
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TLC599 in knee osteoarthritis (OA), sponsored by Taiwan Liposome Company. Started Mar 2017; status: completed.
02
Drugs
TLC599
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03005873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005873.